Through investing in innovative medical tools like microarray patches, we want to reach more people in remote, conflict-affected, and fragile settings with lifesaving vaccinations. Vaccine Microarray Patches (MAPs) allow vaccines to be administered through the skin without needles or syringes. While studies into MAPs are still ongoing, investing into their implementation is critical because they may be advantageous to normal vaccines in low-resource settings. They’re easier to transport, more thermostable (they require less refrigeration), and can be administered by community healthcare workers or volunteers after a brief training – all critical in remote settings far from routine healthcare and where there are often limited numbers of medical professionals available.